Premium Nahrungsergänzungsmittel | artgerecht

Lipocalin 2 (LCN2 / NGAL) – Biomarker & Function

Lipocalin 2 (LCN2) is a naturally occurring protein used as a biomarker for kidney function, inflammation, and metabolic diseases.

Regular tips about health Regular tips about health

Things worth knowing about "Lipocalin 2"

Lipocalin 2 (LCN2) is a naturally occurring protein used as a biomarker for kidney function, inflammation, and metabolic diseases.

What is Lipocalin 2?

Lipocalin 2 (abbreviated LCN2), also known as NGAL (Neutrophil Gelatinase-Associated Lipocalin), is a small protein belonging to the lipocalin family. It is produced in various tissues throughout the human body, including the kidneys, liver, adipose tissue, and immune cells such as neutrophilic granulocytes. Lipocalin 2 plays an important role in the innate immune system and is used as a versatile biomarker in modern medicine.

Biological Functions

Lipocalin 2 fulfills several important roles in the body:

Iron transport and regulation: LCN2 binds siderophores – small molecules capable of transporting iron. By doing so, it deprives bacteria of the iron they need to survive, thereby exerting an antibacterial effect.
Immune defense: As part of the innate immune system, LCN2 supports the defense against infections, particularly those caused by gram-positive and gram-negative bacteria.
Inflammation regulation: LCN2 is released in increased amounts during inflammatory responses and serves as a marker for both acute and chronic inflammatory processes.
Metabolic regulation: In adipose tissue, LCN2 is involved in the regulation of energy metabolism and has been linked to insulin resistance and obesity.
Cell protection: In the kidney, LCN2 exerts a cytoprotective (cell-protective) effect during acute injury.

Lipocalin 2 as a Biomarker

Acute Kidney Injury (AKI)

One of the most important clinical applications of Lipocalin 2 is the early detection of acute kidney injury (AKI). When the kidney is damaged, LCN2 levels in the blood and urine rise within just a few hours of the damaging event – significantly earlier than the classic marker creatinine. This enables faster diagnosis and treatment.

Chronic Kidney Disease

LCN2 can also be used to assess disease progression and the extent of kidney damage in patients with chronic kidney disease (CKD).

Inflammatory Diseases

Elevated LCN2 levels have been observed in a variety of inflammatory conditions, including:

Inflammatory bowel diseases (Crohn's disease, ulcerative colitis)
Rheumatoid arthritis
Sepsis
Heart failure

Metabolic Diseases

LCN2 is also being investigated in connection with type 2 diabetes, obesity, and the metabolic syndrome. Studies suggest that elevated LCN2 levels in the blood may be associated with insulin resistance and increased cardiovascular risk.

Diagnosis and Measurement

Lipocalin 2 is measured using ELISA (enzyme-linked immunosorbent assay) or other immunochemical methods in blood serum, plasma, or urine. Urine measurement is particularly relevant for the early detection of kidney damage, as the kidney releases LCN2 directly into the urine. Reference values may vary depending on the laboratory and measurement method used.

Clinical Significance and Outlook

Lipocalin 2 has established itself as a valuable multi-biomarker used in nephrology, cardiology, endocrinology, and gastroenterology. Researchers are actively investigating the potential of LCN2 as a therapeutic target in kidney disease, inflammation, and metabolic disorders. It should be noted, however, that LCN2 is not a specific marker for any single disease and must always be interpreted within the broader clinical context.

References

Haase M, Bellomo R, Devarajan P, et al. - Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases, 2009.
Moschen AR, Adolph TE, Gerner RR, et al. - Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation. Trends in Endocrinology & Metabolism, 2017.
World Health Organization (WHO) - Global Report on Diabetes. WHO Press, 2016.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.